The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...

The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...

The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...